The US FDA has approved Hibisago, a new injectable treatment for chronic hepatitis B. Clinical trials show promise, but ...
Approval based on Phase 3 data showing unprecedented functional cure rates compared to standard of care – – Six-month ...
Anti-CD36 alloimmunization may contribute to severe platelet transfusion refractoriness despite negative human leukocyte ...
A Guadeloupe study found increased platelet activation and caspase-1 activity in adults with sickle cell disease at steady state, with hemolysis-linked associations concentrated among patients with ...
Approval based on phase III data showing unprecedented functional cure rates compared to standard of care ...
Nutrition education and encouraging pregnant women to engage in antenatal care are key ways to ensure maternal health and ...
Sterling Hospitals successfully treated a 14-year-old with life-threatening hyperinflammatory HLH following dengue, a rare ...
A panelist discusses how ITP diagnosis remains one of exclusion requiring thorough testing to rule out other causes of thrombocytopenia, followed by patient education about autoimmune diseases and ...
A new review in Supportive Care in Cancer reframes chemotherapy-induced thrombocytopenia as a dual destruction of ...
Aspirin is about as ordinary as medicine gets, which is part of why a new dementia finding is turning heads. The idea that such a familiar pill might help prevent dementia is intriguing. What makes ...
Intrauterine PRP was associated with higher pregnancy rates in women with recurrent implantation failure undergoing euploid ...
Kaposiform hemangioendothelioma (KHE) is a locally aggressive vascular tumor that occurs primarily in infants and young ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results